DBV Technologies SA (DBVT)
0.475
-0.01
(-2.68%)
USD |
NASDAQ |
Nov 22, 11:45
DBV Technologies Total Liabilities (Quarterly): 39.02M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 39.02M |
June 30, 2024 | 35.10M |
March 31, 2024 | 34.24M |
December 31, 2023 | 42.80M |
September 30, 2023 | 45.79M |
June 30, 2023 | 53.28M |
March 31, 2023 | 53.84M |
December 31, 2022 | 52.06M |
September 30, 2022 | 36.06M |
June 30, 2022 | 40.56M |
March 31, 2022 | 35.52M |
December 31, 2021 | 47.45M |
September 30, 2021 | 54.03M |
June 30, 2021 | 57.56M |
March 31, 2021 | 52.23M |
December 31, 2020 | 66.76M |
June 30, 2020 | 84.81M |
December 31, 2019 | 78.54M |
September 30, 2019 | 74.89M |
June 30, 2019 | 79.97M |
June 30, 2019 | 79.97M |
Date | Value |
---|---|
December 31, 2018 | 57.72M |
June 30, 2018 | 52.43M |
June 30, 2018 | 52.43M |
December 31, 2017 | 57.45M |
June 30, 2017 | 52.88M |
June 30, 2017 | 52.88M |
December 31, 2016 | 46.96M |
June 30, 2016 | 41.79M |
June 30, 2016 | 41.79M |
December 31, 2015 | 23.18M |
June 30, 2015 | 14.99M |
June 30, 2015 | 14.99M |
December 31, 2014 | 12.12M |
June 30, 2014 | 9.888M |
June 30, 2014 | 9.888M |
December 31, 2013 | 8.066M |
June 30, 2013 | 6.914M |
June 30, 2013 | 6.914M |
December 31, 2012 | 5.028M |
June 30, 2012 | 3.300M |
December 31, 2011 | 5.203M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
34.24M
Minimum
Mar 2024
84.81M
Maximum
Jun 2020
50.54M
Average
49.76M
Median
Total Liabilities (Quarterly) Benchmarks
Edap TMS SA | 40.66M |
Cellectis SA | 266.45M |
Genfit SA | 117.09M |
Adaptimmune Therapeutics PLC | 237.45M |
Akari Therapeutics PLC | 9.428M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 93.06M |
Shareholders Equity (Quarterly) | 54.03M |